ClinVar Miner

Submissions for variant NM_015443.4(KANSL1):c.2110T>C (p.Ser704Pro)

gnomAD frequency: 0.00015  dbSNP: rs202231419
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV001704996 SCV000241325 likely benign not provided 2019-05-17 criteria provided, single submitter clinical testing
Invitae RCV001063848 SCV001228711 benign Koolen-de Vries syndrome 2021-12-07 criteria provided, single submitter clinical testing
Department of Pathology and Laboratory Medicine,Sinai Health System RCV000187728 SCV001554426 benign not specified no assertion criteria provided clinical testing The KANSL1 p.Ser704Pro variant was not identified in the literature nor was it identified in LOVD 3.0. The variant was identified in dbSNP (ID: rs202231419) and ClinVar (classified as likely benign by GeneDx). The variant was identified in control databases in 20 of 282896 chromosomes at a frequency of 0.0000707 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: Other in 1 of 7226 chromosomes (freq: 0.000138), African in 3 of 24968 chromosomes (freq: 0.00012), European (non-Finnish) in 15 of 129198 chromosomes (freq: 0.000116) and Latino in 1 of 35440 chromosomes (freq: 0.000028), but was not observed in the Ashkenazi Jewish, East Asian, European (Finnish), or South Asian populations. This frequency in control populations is inconsistent with what is expected for the rare, early-onset Koolen-de Vries syndrome caused by pathogenic KANSL1 variants. The p.Ser704 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.